New Prostate Cancer Test Ready for General Use

Health Discovery Corporation (HDC) announced Aug. 11 that its new gene-based molecular diagnostic test for prostate cancer has now successfully completed its phase III double-blind clinical trial. According to a Medical News Today report, the test is now ready for commercialization to be used by physicians on their patients at risk of having prostate cancer.

2017-code-book-bundles-728x90-01

Latest posts by admin aapc (see all)

Leave a Reply

Your email address will not be published. Required fields are marked *